President Trump and President-elect Joe Biden both celebrate the news that a coronavirus vaccine being developed by Pfizer and BioNTech has been found to be more than 90% effective in preventing COVID-19 in the trial. Their clinical Stage 3.
This development is an important step towards fighting the global pandemic at a time when many regions are seeing an increase in cases.
BIDEN CORONAVIRUS TEAM INCLUDING RICK BRIGHT, OUSTED HHS OFFICIAL
“BIGGER SECURITIES MARKET, VACCINE IS COMING SOON. REPORTING PERFORMANCE 90%. GREAT NEWS! “Trump tweeted on Monday morning.
Biden also celebrates the success of the trial, but warned that pandemic is still a problem and will likely continue to be one in the coming months.
“I congratulate the outstanding women and men who helped make this breakthrough and give us such hope,”; Biden said in a statement. “At the same time, it is important to understand that the end of the battle against COVID-19 is still many months away. The news follows a previously published timeline by industry officials predicting vaccine approval by the end of November. Even with that being reached, and some Americans are vaccinated at the end. This year, it will be many months before the widespread vaccination in this country ”.
Biden continues to remind Americans to continue to wear masks and to practice away from society and other preventive measures.
USA NEAR 10M CASES OF NO POSITIVE AMID SURGE IN INFECTION WITH THESE THESE STATUS
The vaccine required two doses, and testing started July 27, and involved 38,955 participants who received a second dose on Sunday.
The heads of Pfizer and BioNTech celebrated their breakout as a reason for hope.
“Today is a wonderful day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides preliminary evidence of the vaccine’s ability to prevent COVID-19 ”, Pfizer President and CEO, Ph.D. Albert Bourla said in a statement. “We are hitting this milestone in our vaccine development program at a time when the world needs it most with record-setting infection rates, hospitals nearing capacity and The economy is struggling to reopen. With today’s news, we are taking one step closer to providing people around the world with a much-needed breakthrough to help end this global health crisis.
CLICK HERE TO GET THE FOX NEWS APP
BioNTech CEO and co-founder Ugur Sahin called the results of the experiment “a win for innovation, science and a global collaborative effort” and that “between the second wave and many in We are locked, the more we appreciate the importance of this pivotal milestone on our way towards ending this pandemic and letting us all regain sensibility. “
The companies are expected to produce about 50 million doses of the vaccine this year and up to 1.3 billion doses next year.